Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Academia Sinica joins Lilly’s TB Drug Discovery Initiative
November 2009
SHARING OPTIONS:

SEATTLE—Academia Sinica, a research institution based in Taiwan, announced in October that it will provide target-based screening for the discovery of new tuberculosis (TB) drugs for the Lilly TB Drug Discovery Initiative. The Initiative is a not-for-profit, public-private partnership with a mission to accelerate early-stage drug discovery by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries in search of new TB treatments. The Initiative includes representatives of government agencies, philanthropic organizations, pharmaceutical companies, universities and other research institutions. Its most important goal is filling the pipeline for future TB drugs.          

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.